Plasma Endoglin is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer

Plasma Endoglin is Associated with Favorable Outcome for Pemetrexed-Based Therapy in Advanced Non-Small Cell Lung Cancer

Che-Hsing Li,1,2,* Jiunn-Liang Ko,1,3,4,* Yu-Ping Hsiao,5,6 Ming-Hung Tsai,7 Yen-Chein Lai,8 I-Lun Hsin,3,4 Yu-Ting Kang,3,4 Gwo-Tarng Sheu,1,3,4 Wea-Lung Lin,6,9 Ming-Fang Wu1,4,6 1Divisions of Medical Oncology and Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medi...

Full description

Bibliographic Details
Main Authors: Li CH, Ko JL, Hsiao YP, Tsai MH, Lai YC, Hsin IL, Kang YT, Sheu GT, Lin WL, Wu MF
Format: Article
Language:English
Published: Dove Medical Press 2021-12-01
Series:Cancer Management and Research
Subjects:
endoglin
pemetrexed-based therapy
prognostic factor
non-squamous non-small cell lung cancer
biomarker
Online Access:https://www.dovepress.com/plasma-endoglin-is-associated-with-favorable-outcome-for-pemetrexed-ba-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/plasma-endoglin-is-associated-with-favorable-outcome-for-pemetrexed-ba-peer-reviewed-fulltext-article-CMAR

Similar Items